STUDY DESIGN OF INTRAVENOUS EFGARTIGIMOD IN JUVENILE GENERALIZED MYASTHENIA GRAVIS

被引：0
|
作者：
Kuntz, Nancy L. [1 ]
Bogatyreva, Anna [2 ]
Podhorna, Jana [2 ]
Steeland, Sophie [2 ]
Van Bragt, Tonke [2 ]
Van Hoorick, Benjamin [2 ]
Guglietta, Antonio [2 ]
Howard, James F., Jr. [3 ]
机构：
[1] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Div Neurol, Dept Pediat,Feinberg Sch Med, Chicago, IL USA
[2] argenx, Ghent, Belgium
[3] Univ N Carolina, Chapel Hill, NC USA
来源：
MUSCLE & NERVE | 2022年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [31] PHASE 3 TRIAL INVESTIGATING IMPACT OF INTRAVENOUS EFGARTIGIMOD IN ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY NEGATIVE GENERALIZED MYASTHENIA GRAVIS
    Guptill, Jeffrey
    Jimenez, Rosa H.
    Howard, James F., Jr.
    MUSCLE & NERVE, 2024, 70 (03) : 538 - 538
  • [32] Phase 3 Trial Investigating Impact of Intravenous Efgartigimod in Anti-Acetylcholine Receptor Antibody Negative Generalized Myasthenia Gravis
    Jared
    Guptill, Jeffrey
    Jimenez, Rosa H.
    Howard, James F., Jr.
    ANNALS OF NEUROLOGY, 2024, 96 : S270 - S271
  • [33] Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience
    Antozzi, Carlo
    Frangiamore, Rita
    Rinaldi, Elena
    Vanoli, Fiammetta
    Andreetta, Francesca
    Grigoli, Eleonora Giacopuzzi
    Ciusani, Emilio
    Bonanno, Silvia
    Maggi, Lorenzo
    Mantegazza, Renato
    NEUROLOGICAL SCIENCES, 2025,
  • [34] Efgartigimod in AChR and non-AChR generalized myasthenia gravis: a single center experience
    Antozzi, C.
    Frangiamore, R.
    Rinaldi, E.
    Vanoli, F.
    Bonanno, S.
    Maggi, L.
    Mantegazza, R.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [35] A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFGARTIGIMOD VERSUS RAVULIZUMAB FOR GENERALIZED MYASTHENIA GRAVIS
    Celico, L.
    Spaepen, E.
    De Francesco, M.
    Chiroli, S.
    Iannazzo, S.
    Ruck, T.
    Meuth, S. G.
    VALUE IN HEALTH, 2022, 25 (12) : S20 - S20
  • [36] Correction: A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
    Chiara Pane
    Vincenzo Di Stefano
    Nunzia Cuomo
    Alessio Sarnataro
    Claudia Vinciguerra
    Liliana Bevilacqua
    Filippo Brighina
    Nicasio Rini
    Giorgia Puorro
    Angela Marsili
    Matteo Garibaldi
    Laura Fionda
    Francesco Saccà
    Journal of Neurology, 2025, 272 (5)
  • [37] Clinical Experience With Efgartigimod For Treatment Of Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis
    Katyal, Nakul
    Halldorsdottir, Karen
    Goyal, Neelam
    Govindarajan, Raghav
    Muppidi, Srikanth
    Habib, Ali
    NEUROLOGY, 2023, 100 (17)
  • [38] A real-life experience with Eculizumab and Efgartigimod in generalized myasthenia gravis patients.
    Fionda, L.
    Pane, C.
    Di Stefano, V.
    Cuomo, N.
    Sarnataro, A.
    Vinciguerra, C.
    Bevilacqua, L.
    Brighina, F.
    Rini, N.
    Puorro, G.
    Marsili, A.
    Garibaldi, M.
    Sacca, F.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [39] Efgartigimod demonstrates consistent improvements in patients with generalized myasthenia gravis of shorter disease duration
    Genge, Angela
    Bril, Vera
    Vu, Tuan
    Brauer, Edward
    Kerstens, Rene
    Howard, James F., Jr.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [40] Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single Center
    Silvestri, Nicholas J.
    MUSCLE & NERVE, 2025, 71 (03) : 422 - 428
12345